Q4 2018 and FY 2018 Net Sales

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
Q4 2018 and FY 2018 Net Sales

Paris, 11 th February 2019

Q4 2018 and FY 2018 Net Sales

Top-line decrease in France and the Americas partially offset by growth in Poland

Marie Brizard Wine & Spirits (Euronext: MBWS) today announced its non-audited net sales for Q4 2018, covering the reporting period from 1 st October to 31 st December 2018, and full-year 2018.

Q4 2018 Net sales

The Group’s consolidated non-audited Q4 2018 net sales totaled €99.5m [1] , a -6.2% [2] decrease compared to Q4 2017.  The Branded Business accounted for 58.3% of total net sales, marking a sequential improvement in consolidated revenue mix versus the Branded Business accounting for 49.7% of net sales in Q3 2018.

Q4 2018 net sales, by cluster

  In €m IFRS 15 Q4 2017 restated 1 Organic Growth Forex impact Q4 2018 Organic Growth (excl.foreign exchange impact) Reported growth (incl.foreign exchange impact)
               
Branded Business 63.8 -6.1 0.3 58.0 -9.6% -9.1%
WEMEA 35.3 -3.5 0.1 31.9 -10.0% -9.6%
  France 28.4 -4.1 0.0 24.3 -14.6% -14.6%
  Rest of cluster 6.9 0.6 0.1 7.6 8.5% 10.7%
CEE 16.6 2.5 0.3 19.4 15.1% 17.2%
  Poland 8.5 1.5 0.3 10.3 17.1% 21.0%
  Rest of cluster 8.0 1.1 0.0 9.1 13.1% 13.1%
Americas 10.1 -4.5 -0.2 5.4 -44.3% -45.9%
Asia Pacific 1.8 -0.6 0.0 1.2 -34.0% -34.1%
Other Businesses 40.9 -0.3 0.9 41.5 -0.8% 1.3%
  Sobieski Trade 24.7 0.7 0.9 26.3 2.8% 6.3%
  Private Label 16.2 -1.0 0.0 15.2 -6.3% -6.3%
  TOTAL MBWS 104.7 -6.4 1.2 99.5 -6.2% -5.0%

Western Europe, Middle East and Africa (WEMEA):  Sales declined in France, partially offset by growth in the rest of the cluster

In France, Q4 2018 net sales totaled €24.3m, a -14.6% decrease compared to the previous year.  Revenue was affected by the decline in sales evident across the overall spirits sector in France since the first half of 2018, and further exacerbated by the social movements in November and December, which have affected most consumer goods categories.  In Q4 2018, the value of the spirits market decreased by -3.0% [3] , with MBWS’ main categories continuing to underperform the overall sector.  The value of the vodka sector declined -6.1% 3 , Scotch whisky decreased -3.4% 3 , and flavored wines decreased -6.5% [4] .   The Group’s net sales underperformance during the quarter is due primarily to a decrease in volumes, attributable to a lower level of promotions carried out by MBWS, in contrast to intense promotional activity by competitors, particularly in the scotch whisky and vodka categories.  The sparse availability of 2017 vintage rosé also had a negative impact on MBWS’ Q4 net sales.

In the rest of the WEMEA cluster, net sales grew to €7.6m, a +8.5% increase compared to last year.  This result was driven by solid sales growth in Spain, reflecting the positive impact of a double-digit price increase, which has been well-accepted by the market.

Central and Eastern Europe (CEE): Double-digit top-line growth in Poland, and a return to growth in the rest of the cluster

In Poland, Q4 2018 net sales grew +17.1% versus Q4 2017, to €10.3m, providing evidence of the progressive recovery from the proactive destocking in H1 2018.  Sales growth in Poland was driven by a net sales increase in the modern trade, and by the gradually accelerating execution of distribution agreements signed in the second half of 2018. 

In Lancut, final testing is being carried out and most of the required authorizations were recently obtained.   Operations at the new distillery are scheduled to begin in the coming weeks.

In the rest of the CEE cluster, Q4 2018 net sales reached €9.1m, an increase of +13.1%, marking a return to growth.  Sales growth in Lithuania reflects the full impact of pricing increases taken earlier in the year, and the                                                                                                                                                                                                                                                                                  restrictive but consistent regulatory environment regarding the sale of alcohol since the second half of 2017.  Sales activity in Bulgaria also generated solid growth. 

Americas: Sales decrease due to ongoing destocking and pricing pressure

In the Americas cluster, net sales totaled €5.4m.  As anticipated and previously mentioned, in the United States top-line decreased sharply with continued destocking of Sobieski in some regional markets into Q4 2018.  Consequently, net sales in the cluster were down -44.3% as compared to Q4 2017 (with a challenging comparable base of +10.8%).  Additionally, pricing pressure accelerated in the US vodka market over the holiday season, with overall pricing in the category moving downward, and a consequent negative impact on Sobieski’s net sales.     

A top-line decrease in Brazil, due primarily to a challenging comparable base, also contributed to the overall sales decline in the Americas cluster during this reporting period.

Asia Pacific

Net sales in the Asia Pacific cluster totaled €1.2m in Q4 2018, a decrease of -34.0% versus last year off of a low base, and in-line with Q3 2018 net sales.  In Asia, the distribution agreements in place have not enabled the Group to meet its objectives.  The new strategic plan will put forth a new approach to the route-to-market in this cluster. 

Other Businesses

Net sales for Other Businesses in Q4 2018 totaled €41.5m, a decrease of -0.8%.  The  dynamics evident in the third quarter of 2018 continued, with net sales at Sobieski Trade growing +2.8%, while a decrease in private label wine led to an overall  -6.3% sales decrease in the Private Label business.

Events after year-end 2018

Principal Option of the agreement between MBWS and COFEPP approved by a large majority of shareholders; French Financial Markets Authority (AMF) authorization granted

The Principal Option of the agreement between MBWS and COFEPP, presented at the AGM on 31 January 2019, was approved by 89% of voting shareholders (with COFEPP excluded from the vote). 

This option is based on the agreement of 21 December 2018 between MBWS and COFEPP (as modified by an addendum on 30 January 2019) for a Reserved Capital Increase (RCI) and subsequent free stock warrant program for all shareholders.  The capital increase should provide a minimum of €45m in new money to MBWS.  

As set out under the terms of the agreement between Marie Brizard Wine & Spirits and COFEPP, a €25m bridge loan was granted by COFEPP to MBWS on 4 February 2019.  This loan will be repaid to COFEPP by an offsetting receivable within the framework of the COFEPP Reserved Capital Increase that is expected to take place at the end of February. 

This operation is subject to COFEPP obtaining an exemption by the French Financial Markets Authority (AMF).  The required exemption was granted on 5 February 2019.  The operation is also subject to prior authorization of the anti-trust authorities in Poland.  This authorization was obtained today.  The operation is additionally subject to the authorization from the French anti-trust authorities under conditions considered acceptable by COFEPP; this decision is expected to be received by the end of the February 2019.  

Marie Brizard Wine & Spirits produces and sells a range of wine and spirits across four geographic clusters: Western Europe, Middle East & Africa, Central and Eastern Europe, the Americas, and Asia-Pacific. MBWS has distinguished itself for its know-how, the range of its brands, and a long tradition and history of innovation. From the inception of Maison Marie Brizard in Bordeaux, France in 1755, to the launch of Fruits and Wine in 2010, MBWS has successfully developed and adapted its brands to make them contemporary while respecting their origins. MBWS is committed to providing value by offering its customers bold, trustworthy, flavorful and experiential brands. The company has a broad portfolio of leading brands in their respective market segments, most notably William Peel scotch whisky, Sobieski vodka, Krupnik vodka, Fruits and Wine flavored wine, Marie Brizard liqueurs and Cognac Gautier. MBWS is listed on the regulated market of Euronext Paris, Compartment B (ISIN code FR0000060873, ticker MBWS) and is included in the EnterNext© PEA-PME 150 index, among others.

                                            

Investor Contact Raquel Lizarraga  raquel.lizarraga@mbws.com Tél : +33 1 43 91 50 Press Contact Simon Zaks, Image Sept szaks@image7.fr Tél : +33 1 53 70 74 63  

ANNEX

Full Year 2018 net sales, by cluster (IFRS 15)

  In €m IFRS 15 FY 2017 restated Organic Growth Forex impact FY 2018 Organic Growth (excl.foreign exchange impact) Reported Growth (incl.foreign exchange impact)
               
Branded Business 230.7 -34.2 -0.7 195.8 -14.8% -15.1%
WEMEA 131.7 -13.5 0.1 118.4 -10.3% -10.2%
  France 108.9 -12.1 0.0 96.9 -11.1% -11.1%
  Rest of cluster 22.8 -1.5 0.1 21.5 -6.4% -5.8%
CEE 69.0 -12.1 0.4 57.3 -17.5% -16.9%
  Poland 39.8 -11.2 0.4 29.0 -28.2% -27.2%
  Rest of cluster 29.2 -0.9 0.0 28.3 -3.0% -3.0%
Americas 25.6 -7.3 -1.2 17.0 -28.6% -33.5%
Asia Pacific 4.4 -1.3 0.0 3.1 -29.2% -29.4%
Other Businesses 184.1 8.0 1.2 193.3 4.4% 5.0%
  Sobieski Trade 100.2 6.1 1.2 107.5 6.1% 7.3%
  Private Label 83.9 1.9 0.0 85.8 2.3% 2.3%
  TOTAL MBWS 414.7 -26.2 0.5 389.0 -6.3% -6.2%

[1] The IFRS 15 Accounting Standard regarding “Revenue from contracts with customers” has been in effect since 1 st January 2018.  Marie Brizard  Wine & Spirits has thus published its 2017 and 2018 quarterly and full-year net sales according to this accounting standard.

[2] All growth rates mentioned in this press release are calculated at constant exchange rates on a like-for-like basis, unless otherwise stated.  The figures provided at a constant exchange rate are calculated by applying the exchange rate from the year-ago period to the net sales figure of the current reporting period.

[3] Source: Nielsen, P11 – P13, in  value

[4] Source: IRI, P11 – P13, in value

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 476

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 599

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 446

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 16

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 56

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 477

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 572

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Check Printing with ezCheckPrinting Today

Updated Category News Views 194

Revolutionary Check Printing Solutions for Businesses In today's fast-paced business environment, efficient solutions are essential. One innovative tool that has emerged is the ezCheckPrinting software, combined with a virtual printer, designed specifically for QuickBooks and Quicken users. This powerful combination facilitates unlimited check printing directly onto blank...

Continue Reading
Kelso Technologies' 2025 Strategies for Growth and Stability

Updated Category News Views 488

Kelso Technologies' Strategic Outlook for 2025 Kelso Technologies Inc (TSX: KLS) has outlined its ambitious goals for 2025 amid a recovering economy. The Board of Directors has given the green light to a budget that anticipates a sales growth margin between 0% to 5% compared to the previous fiscal year. The company expects revenues for fiscal year 2024 to reach...

Continue Reading
Revelation Biosciences Launches Clinical Trial for Chronic Kidney Disease

Updated Category News Views 195

Revelation Biosciences Launches PRIME Phase 1b Clinical Study Revelation Biosciences, Inc. is embarking on an exciting chapter as it announces the initiation of its PRIME Phase 1b clinical study aimed at examining the effects of Gemini, a proprietary formulation designed to assist in the treatment of Chronic Kidney Disease (CKD). The company, focused on leveraging the...

Continue Reading
Auction Outcomes for Treasury Bills on November 28, 2024

Updated Category News Views 237

Overview of Treasury Bills Auction Results The auction for treasury bills held on a recent date revealed important data regarding bids, sales, and prices. Investors and market analysts keep a close eye on these outcomes to gauge market conditions and make informed decisions. Detailed Auction Data The following section provides comprehensive details on the bids, sale...

Continue Reading
IMC Rare Earths IPO Debuts Amid Fed Rate Focus

Updated Category News Views 27

Rare Earths and Rate Talks Steal the Spotlight You ever feel like every time you look at the market, something’s ready to pop or drop? Today’s no exception, with IMC Rare Earths making its grand debut while everyone's ears are peeled for the Fed. Now, a fresh pair of dice are rolling on Wall Street, as IMC steps onto the NYSE American. Breaking Down the IMC IPO This...

Continue Reading